Introduction
For the past two decades, research on species of the genus Burkholderia has been steadily expanding, so that the genus Burkholderia currently comprises more than 60 species, isolated from remarkably diverse ecological niches such as river water, soil, freshwater sediments and plant rhizosphere, and including also human, animal and plant pathogens [1] . The natural diversity of members of this genus indicates that the range of interactions between these bacteria and their hosts is very complex, diverse, and, often, contradictory. The ecological and metabolic versatility of this genus ranges from the ability to proliferate in lungs of cystic fibrosis (CF) patients causing often mortal infections to that of growing inside plant tissues as obligate endosymbionts, from the ability to degrade recalcitrant xenobiotic compounds to that to protect crop plants by synthesizing antifungal compounds.
Since the establishment of this genus [2] , research has been focused primarily on two highly pathogenic species such as B. mallei and B. pseudomallei and on species belonging to the so-called B. cepacia complex [1, 3] . The latter is a group of 17 species, widely distributed in the environment, able to promote plant-growth and to antagonize plant pathogens, but it is also reported to contain opportunistic human pathogens, so that any biotechnological application is, at least temporarily, not allowed. Nevertheless, in recent years, a growing number of new Burkholderia species have been discovered and reported as nitrogen fixing, non pathogenic plant-growth promoting bacteria, thus being proposed as candidates for biotechnological applications [4] .
Over the past few years, sequencing of more than 35 Burkholderia genomes has made available to the scientific community a huge amount of data that can significantly contribute to better define the pathogenicity and the biotechnological potential of the different Burkholderia species and help clarify the genetic basis of the great ability of members of this genus to adapt to extremely diverse habitats. This article presents highlights from recent studies on the taxonomy, ecology and pathogenicity of different species of the Burkholderia genus with the aim to evaluate their potential use for biotechnological applications.
Taxonomy and ecology
Burkholderia is a phylogenetically coherent genus within the β-proteobacterial subphylum, which was first described by Yabuuchi and colleagues (1992) [2] by transferring seven species from the Pseudomonas genus, with Burkholderia cepacia as the type species. Since then, more than 50 validly named species and candidate species have been added to this genus. So far, the most comprehensive phylogenetic analysis of Burkholderia species are based on 16S rRNA, recA and acdS genes [5] . They all point out that there are two main lineages in this genus: one is composed largely of pathogens, whereas the other includes mainly environmental isolates that may form non-pathogenic associations with plants.
The first lineage includes human, animal and plant pathogens (Burkholderia cepacia complex (BCC) species, B. mallei, B. pseudomallei, B. plantarii, B. gladioli, B. glumae, etc.). Three minor subgroups are also recognizable, corresponding to BCC, B. pseudomallei group and plant-pathogens group. The BCC is a collection of genetically distinct but phenotypically similar bacteria that belong to at least 17 species [1] . BCC species have been isolated from a variety of natural habitats such as plant rhizosphere, soil and river water and from several urban environments such as playgrounds and athletic fields, and although first described as the causal agent of onion rot, they have generally useful properties for biocontrol, bioremediation and plant growth promotion [6] . However, BCC bacteria are also recognized as important opportunistic pathogens that can cause variable lung infections in cystic fibrosis patients, which result in asymptomatic carriage, chronic infection or 'cepacia syndrome', which is characterized by a rapid decline in lung function and can include invasive disease and death.
B. pseudomallei and B. mallei are two highly pathogenic bacteria, responsible for melioidosis and glanders, respectively [3, 7] . Melioidosis, which affects humans, is endemic in Southern Asia and northern Australia, and its etiological agent, B. pseudomallei, is an environmental saprophyte that is commonly found in wet soils and stagnant waters throughout the endemic regions [3] . B. mallei, the etiological agent of glanders, cannot persist in the environment outside its equine host. Horses are the primary carriers of disease and are largely responsible for transmitting the infection to healthy animals and humans [3] . These two species are phylogenetically very similar and have nearly identical 16S ribosomal DNA sequences. They have been defined as separate species essentially due to their epidemiological and sanitary features. B. thailandensis, the third and last member of this subgroup, is non pathogenic for humans and was previously described as a non pathogenic variant of B. pseudomallei [8] .
The so-called phytopathogenic subgroup includes some well known and wide spread plant pathogens such as B. andropogonis, B. glumae, and B. plantarii. B. glumae is an emerging seed-borne rice pathogen in many areas around the world and is known to be the etiologic agent of the so-called panicle blight, which can cause severe crop yield losses as high as 40% [9] . B. andropogonis has been long known as the causal agent of several plant diseases such as stripe disease of sorghum and leaf spot of velvet bean, and more recently it has been described as the cause of brown leaf spot of citrus [10] . It is remarkable that B. rhizoxinica and B. endofungorum, endosymbiotic bacteria, which live within the cells of the fungus Rhizopus microsporus and produce the causal agent of rice seedling blight, rhizoxin, and the toxic cyclopeptide rhizonin, do not group with the other endosymbiotic species of the non-pathogenic cluster, but are very close to the pathogenic species B. mallei and B. pseudomallei as well as to B. caryophylli, a parasitic endophytic species infecting vascular plants [11] . It is worth noting that recently B. rhizoxinica and B. endofungorum have also been recovered from clinical specimens, probably as a consequence of patient infection by the fungus Rhizopus [12] .
The second and more recently established lineage in the genus Burkholderia comprises more than 25 related environmental species, which in most cases are non-pathogenic and have been found to be associated with plants [4] . Several interesting properties found in members of this cluster include (i) the strong catabolic potential to degrade aromatic compounds, with B. xenovorans being the best known example; (ii) the potential to increase plant nutrient availability via nitrogen fixation and/or phosphate solubilisation, as demonstrated for B. unamae, B. tropica, and B. silvatlantica; (iii) the ability to colonize the rhizosphere or the internal intercellular spaces in several plants and promote plant growth, as is the case for B. kururiensis and B. phytofirmans; and (iv) the ability to form symbiotic interactions with plants as occurs, for example, with B. tuberum, B. phymatum, B. mimosarum, B. nodosa, and B. sabiae, and with mosses, as reported for B. megapolitana and B. bryophila. Although root-nodule symbionts, like pathogens, form an intimate association with their eukaryotic hosts, all the symbiotic Burkholderia isolates belong to the non-pathogenic lineage.
Pathogenicity of Burkholderia species
The most important Burkholderia species in terms of pathogenic potential are B. mallei, B. pseudomallei and the BCC species [13] . B. mallei and B. pseudomallei have been long known to be the causative agents of the highly infectious equine disease known as glanders and of melioidosis, potentially fatal infections of equines and humans, respectively. Both bacterial species are facultative intracellular pathogens that can invade and replicate inside epithelial and phagocytic cells and possess an arsenal of recently identified virulence determinants Indeed, capsule, type III secretion system (T3SS), and type VI secretion system (T6SS) have emerged as key virulence factors of both B. mallei and B. pseudomallei. However, knowledge on the T3SS-and T6SS-secreted effectors remains limited [3] . By the 1980s, the BCC had emerged as a significant problem in CF clinics around the world, with some CF centers reporting prevalence rates as high as 40%, due also to the spread of highly transmissible strains [6] . To date, prevalence rates have dropped dramatically worldwide also because of the introduction of efficient segregation measures. Of the 17 species included in the BCC, a clear clinical impact on CF patients has been so far proven only for B. cenocepacia, B. multivorans, and B. dolosa. Some anecdotal evidence of a link to worsening of health status of CF patients has been reported for B. stabilis and B. vietnamiensis [6] . For all other BCC species, no strong causal association has so far been established between the presence of such species in pulmonary secretions and the health decline in CF patients. As far as non-CF patients are concerned, BCC detection is uncommon and the relevance for these patients is unclear, although recently a major outbreak of B. contaminans was reported in a non-CF clinical setting, affecting more than sixty patients [14] .
As far as BCC pathogenicity is concerned, research has focused mainly on B. cenocepacia because of its high prevalence among CF patients. According to Loutet and Valvano [15] , most studies point out that determinants mediating host niche adaptation are more involved in the establishment of chronic infections by B. cenocepacia than those involved directly in host cell and tissue damage. Indeed, the best characterized virulence determinants in B. cenocepacia include molecules required for resistance to host antimicrobial compounds, secretion systems, extracellular and cell surface polysaccharides, systems that regulate gene expression, etc. Such factors have more to do with adaptation for survival under changing conditions, which is likely necessary for establishing chronic infections, than with mounting a potent acute infection [15] .
All BCC species can be isolated from clinical samples as well as from the natural environment, which could be acting as a constant "reservoir" for infectious BCC pathogens [16] . Furthermore, most BCC species include isolates of both clinical and environmental origin showing the same sequence type (ST) by multi locus sequence typing (MLST), i.e. belonging to the same strain. In particular, all species whose isolates have been proven to have biotechnological potential, such as B. cepacia, B. cenocepacia, B. vietnamiensis and B. ambifaria, include STs shared by both clinical and environmental isolates. These findings suggest that the conservation of intrinsic determinants necessary to thrive in environmental niches may confer the ability to colonize susceptible humans. In fact, in a successive study, B. cenocepacia strain POPR8, isolated from a radish in Mexico and sharing the same ST with other isolates from CF sputum, was shown to persist in high numbers in the lungs of infected mice, with high infection rate, confirming the pathogenic potential of environmental strains [17] . Vial and colleagues [18] suggest that B. ambifaria uses phase variation, an adaptive process conferring to bacteria the capacity to adapt to fluctuating environmental conditions and to drastically different environments, such as the lungs of patients with CF or the plant roots environment, again reinforcing the idea that differentiation between environmental and clinical isolates of Bcc, as far as health hazard is concerned, is unrealistic.
So far, most members of the so-called nonpathogenic lineage have not been associated to human disease. Perin and colleagues [19] observed that some putative virulence and/or transmission markers that are widely spread among clinical and environmental isolates of BCC species, are completely absent among plant-associated nitrogen-fixing Burkholderia species. However, the rhizosphere, where species of the pathogenic and non-pathogenic Burkholderia clusters can be recovered in high numbers, is supposed to function as a hot spot for high-rate transfer of genes between related rhizobacteria (e.g. Burkholderia, Pseudomonas and Stenotrephomonas species) [20] . This raises concerns about the possibility of DNA exchange among strains that belong to different Burkholderia species. This would, in principle, enable an apparently harmless Burkholderia strain to acquire pathogenicity traits from a virulent neighbour. Stringent assessment of risk to human health associated with the release into the environment of harmless nitrogen-fixing Burkholderia strains should evaluate such possibility, but, unfortunately, no experimental data are available so far. Recently, a few species belonging to the nonpathogenic cluster have been linked with human disease. B. tropica and B. fungorum have been reported to be the causative agents in two cases of septicaemia [21, 22] , while strains belonging to B. caledonica and B. xenovorans have been isolated from human clinical samples [23, 24] . At present it is difficult to interpret these findings in terms of broader clinical significance because of the limited number of cases; in particular, for the latter two species, no cases have been reported where a causal association has been established between the presence of such species and human disease.
Genomics and transcriptomics
The number of whole-genome sequences is rapidly increasing; so far, over 
com).
There is a growing interest in using these whole-genome sequences not only for taxonomic and evolutionary studies, but also for investigation of pathogenicity mechanisms and adaptation ability to very diverse habitats of the different Burkholderia species.
Although this genus is phylogenetically coherent, as mentioned above, Burkholderia species occupy extremely diverse ecological niches. Whole-genome sequencing of strains belonging to species thriving in different habitats can give information to explain the high adaptability to different environmental conditions of members of this genus, i.e. to find the genetic determinants which favour bacterial growth in so different niches. This is particularly true in the case of genetic determinants involved in human and plant pathogenicity, which is one of the main reasons for genome sequencing of Burkholderia species. Recently, Lim and colleagues [25] have published the complete genome sequence of B. glumae; this species was chosen because it is the etiologic agent of rice panicle blight, a disease which is spreading quickly in most Asian rice-growing countries, and because B. glumae can represent a good model to understand how plantpathogenic bacteria infect rice panicles and flowers and, more in general, how pathogenic bacteria and plants interact.
Most Burkholderia species have a minimum of two chromosomal replicons and a genome size ranging from 6 to 9 Mbp, and hence encode over 7000 genes. It is also clear from their genomes that 10% or more of these 7000 genes appear to have been acquired through horizontal gene transfer; indeed, they all contain elements of foreign DNA such as genomic islands, integrated phages or plasmids and an array of insertion sequences, which promote genomic plasticity and general adaptability [26] . All these features are claimed to be the basis for the very high ecological and metabolical versatility of the members of this genus. In fact, large genomes have been described as disproportionately enriched in regulation and secondary metabolism genes and depleted in protein translation, DNA replication, cell division and nucleotide metabolism genes in comparison with small-sized genomes. This may explain why species containing large genomes dominate in environments, such as soils and plants, where resources are scarce but diverse. For example, the species B. xenovorans shows considerable intraspecies genomic variation and the size of its genome may vary up to 2.3 Mbp (from 7.4 to 9.6 Mbp). This can be largely explained by more than 20% of sequences acquired by means of lateral gene transfer. In general, a large fraction of the differences in gene content within species is associated with bacteriophage and transposase elements, revealing an important role of these elements during bacterial speciation. Environmental behaviours of strains and species of the genus Burkholderia may have modulated the genome sizes and content of these proteobacteria, which are thus capable of flexibility, plasticity and versatility and make them adaptable to various microbial niches.
The extensive genomic datasets are very useful in allowing the genetic basis for the pathogenesis and environmental versatility of Burkholderia species to be studied in more detail. For example, as mentioned above, many BCC genome sequences are publicly available (http://www.genomesonline.org/); in particular, the genomes of five strains of B. cenocepacia, one of the most virulent and problematic CF pathogens, have been completed so far: J2315, AU1054, PC-184 (representing the three major lineages based on recA gene polymorphism, i.e. IIIA, IIIB and IIID), HI2424 (a soil isolate), and MC0-3 (a rhizosphere isolate) [27] . Through comparative genomics it will be possible to identify and select novel vaccine targets and also to detect genes that are shared among species of related pathogens or are distinct in pathogenic attenuated or naturally non-pathogenic strains or species. However, such sequence-based approaches applied to BCC bacteria cannot predict those genes that will be expressed preferentially in the lung of CF patients or in the rhizosphere of crop plants so that recent research on the molecular pathogenesis of these bacteria has focused on global gene expression studies.
In particular, transcriptomic approaches, based on microarray and RNA-seq techniques, have been used to examine mechanisms of virulence in B. cenocepacia [28, 29] . By using a microarray technology or cDNA sequencing, several global gene expression studies of B. cenocepacia that model environmental and infectionrelated interactions have been made available. Using direct high-throughput Illumina sequencing of cDNAs, Yoder-Himes and colleagues [28] investigated the transcriptomes of two related strains of B. cenocepacia isolated from two very disparate habitats, a CF patient and soil from an agricultural field. All these studies allowed the identification of many genes induced under CF conditions that may constitute, at least some of them, particularly attractive therapeutic targets due to their signal sequence, predicted cellular location, and homology to known therapeutic targets. Moreover, by means of these approaches, a deep insight into adaptation strategies of environmental and clinical strains of B. cenocepacia is gained through the analysis of differences in gene expression on a global scale.
Burkholderia xenovorans strain LB400 is one of the most important aerobic polychlorinated biphenyl (PCB) degraders yet discovered (see also the 'Biotechnology' section). The pathways for degradation of PCBs by strain LB400 have been extensively characterized at both the genetic and the molecular level [30, 31] and the complete sequencing of the LB400 genome (http://genome.ornl.gov/microbial/bfun) [32] , one of the largest ones among prokaryotes (9.7 Mb), greatly contributed to the investigation of the biology of PCB degradation. By use of genomic and proteomic approaches, an outline of genome-wide responses to a range of carbon and cell development conditions has been reported [33, 34] . Putative detoxification mechanisms were also revealed during analysis of the transcriptome of B. xenovorans LB400 [35] and recent studies, aimed at exploring the effect of environmental conditions (e.g., carbon source and growth phase) on the variation in PCB degradation profiles of Burkholderia xenovorans LB400, revealed 25 potential genes involved in the activation of mechanisms beyond the biphenyl pathway that provide stability and improve PCB degradation [36] .
It is remarkable that within the Burkholderia genus, beside human pathogenic species, there are several species that are endosymbionts with different hosts, such as fungi, plants and mosses. Thus, this genus can represent a model system to understand how symbiosis and pathogenesis have emerged, spread and evolved within a single bacterial genus. The wholegenome sequence of B. rhizoxinica, completed earlier this year, represents an excellent basis to investigate bacterium-fungus interactions [37] . Recently, another whole-genome sequence of an endosymbiontic species has been completed, i.e. that of B. phymatum (http://www.burkholderia.com). This species is capable of fixing nitrogen from the atmosphere and of nodulating roots of plants, such as Phaseolus vulgaris, Mimosa invisa and M. pudica. Comparison of the two genomes will certainly shed light on commonalities and difference in their genetic equipment necessary to establish symbiosis with their hosts.
Biotechnology
In the last two decades, most Burkholderia candidates for biotechnology application, particularly as biofertilizers in agriculture, belonged to the BCC. Unfortunately, all BCC species have been recovered from both clinical and environmental samples and their biotechnological use is currently not permitted [6] . As mentioned above, the clinical significance, except for B. cenocepacia, B. multivorans, B. dolosa and few other species, is still unclear. However, the distinction between environmental and clinical strains of BCC cannot be the basis to distinguish safe from unsafe strains, because the environment is a source of pathogenic strains. Therefore, the risk to human health associated with the release into the environment of BCC isolates which have been proven to be good plant-growth promoting agents and plant pathogen antagonizers, as reported by many authors, is too high. Thus, it is hardly foreseeable that the ban on biotechnological use of BCC bacteria will ever be lifted.
By contrast, the newly described nitrogen-fixing Burkholderia species, associated with the rhizosphere of different crop plants and belonging to the nonpathogenic Burkholderia lineage, could have a great potential for biotechnological applications in plant growth promotion, biological control of plant pathogens, and, concomitantly, in rhizoremediation and/or for improvement of phytoremediation, and, finally, in biomining [4] .
Among the Burkholderia species belonging to the nonpathogenic lineage, B. tropica shows the highest mineral phosphate-dissolving capability [38] . Its remarkable ability to convert insoluble mineral phosphorus to an available form to plants is an important trait for allowing this nitrogen-fixing species to be defined as a plant growth-promoting rhizobacterium. Seed inoculation with efficient phosphate-solubilizing bacteria is known to increase solubilisation of fixed soil phosphorus and immobilized phosphates in the soil after application of mineral fertilizers, resulting in higher crop yields. B. tropica has also been suggested as a candidate for biological control of pathogenic nematodes since they are strongly associated with less pathogenic nematodes and weakly associated with highly pathogenic ones [39] .
Efficient phosphate-solubilizing bacteria could also be economically useful in emerging industrial activities such as biomining [40] ; in particular, manufacturing of metallic iron and steel from iron ore resources requires the previous removal of phosphorus. The use of the novel species B. ferrariae, isolated from a high phosphorus iron ore and able to solubilise highly insoluble phosphatic minerals, could contribute to solve this problem in a cost-effective and environment-friendly way.
The ability of B. unamae to grow using aromatic hydrocarbons, in particular benzene and phenol, as well as its widespread association with different plant species, suggests that it could be suitable for applications in rhizosphere remediation of common soil pollutants [38] . In addition, taking into consideration the host plant range of B. unamae and its endophytic character, it would be of great interest to know the natural ability of this species to improve phytoremediation of volatile organic pollutants, as has been suggested with the application of engineered endophytic BCC bacteria, which, unfortunately, will not be possible to use because of their pathogenicity. Indeed, phytoremediation of highly water soluble and volatile xenobiotics is often inefficient because plants do not completely degrade these compounds through their rhizospheres. This results in phytotoxicity and/or volatilization of chemicals through the leaves, which can cause additional environmental problems. According to Barac and colleagues [41] and Weyens and colleagues [42] , endophytic bacteria equipped with the appropriate degradation pathway improve the in planta degradation of toluene. For example, B. cepacia L.S.2.4, a natural endophyte of yellow lupine, equipped with the pTOM toluene-degradation plasmid of Burkholderia vietnamiensis G4 strongly degraded toluene, resulting in a marked decrease in its phytotoxicity, and a 50-70% reduction of its evapotranspiration through the leaves [41] . This strategy promises to improve the efficiency of phytoremediating volatile organic contaminants.
Polychlorinated biphenyls (PCBs) are toxic xenobiotics, manufactured during the mid-twentieth century as congener mixtures and used in hydraulic and heat-transfer systems, inks, lubricants, paints, and adhesives. Due to remarkable chemical and thermal stability, their persistence in the environment is very high and there is still a scarcity of treatment options for contaminated soils and sediments, with very few alternatives to in situ treatment. A large number of PCB degrading organisms have been isolated; among these, B. xenovorans has raised much interest among being one of the best aerobic PCB degrader discovered so far. Its capacity to oxidize more than 20 PCB congeners, with up to six chlorine substitutions on the biphenyl rings [43] as well as its ability to use some congeners as sources of carbon and energy [44, 45] made it the model organism for PCB biodegradation studies.
Conclusions
The Burkholderia genus includes species whose ecological properties can differ enormously from each other, and new species colonizing amazingly different habitats are continuously discovered. Over the past few years, a wealth of new information about the taxonomy, ecology, epidemiology and pathogenicity of Burkholderia species, in particular of BCC, has been gathered thanks to the extensive implementation of MLST and genomic sequencing and the recent application of transcriptomics and proteomics. Although differences in the pathogenic and ecological properties among BCC species have been confirmed, such differences do not warrant a reconsideration of the possibility of using these organisms in biotechnology. However, the pioneering work carried out in the laboratory of the late Professor Jesus Caballero-Mellado on nitrogen-fixing bacteria (see references [4, 5, 19, 38] ) greatly helped to bring to light an entire group of new non-pathogenic nitrogenfixing Burkholderia species that are serious candidates for biotechnological applications, in particular in the field of plant-growth promotion and phytoremediation.
